Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.390
+0.080 (6.11%)
At close: Jan 17, 2025, 4:00 PM
1.340
-0.050 (-3.60%)
Pre-market: Jan 21, 2025, 4:49 AM EST
Intelligent Bio Solutions Revenue
Intelligent Bio Solutions had revenue of $872.29K in the quarter ending September 30, 2024, with 9.57% growth. This brings the company's revenue in the last twelve months to $3.19M, up 55.29% year-over-year. In the fiscal year ending June 30, 2024, Intelligent Bio Solutions had annual revenue of $3.11M with 147.58% growth.
Revenue (ttm)
$3.19M
Revenue Growth
+55.29%
P/S Ratio
1.09
Revenue / Employee
$63,759
Employees
50
Market Cap
6.10M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
INBS News
- 6 days ago - Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK Sites - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results - GlobeNewsWire
- 3 months ago - Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles - Newsfile Corp
- 3 months ago - Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek - GlobeNewsWire